← Studies & programmes
Myelin repairPhase 1/2 study in people — safety and possible benefitResearch, not an established treatment
ReINFORCE: a planned clemastine study for recent myelin damage
Published by MyelinWatch:
ReINFORCE · Researchers plan to test clemastine in people with recent areas of myelin loss, using MRI measures to look for possible repair.
What is being studied
Researchers plan to test clemastine in people with recent areas of myelin loss, using MRI measures to look for possible repair.
Research stage
Phase 1/2 study in people — safety and possible benefit
The study is not yet accepting participants.
What we know so far
The Phase 1/2 study is not yet taking participants according to its current listing. No study results are available.
What this means for patients today
The study is not yet taking participants. Clemastine is not established as a treatment for this purpose.
- Treatment or approach
- Clemastine • recent areas of myelin loss
- How it is intended to work
- Uses clemastine to block certain receptors and encourage myelin-making cells to mature
- Where the study is running
- Centre at UCSF, United States • not yet accepting participants
- Published by MyelinWatch
- Last substantive MyelinWatch update